Skip to main content
Top
Published in: Annals of Nuclear Medicine 3/2017

Open Access 01-04-2017 | Original Article

An automated voxel-based method for calculating the reference value for a brain tumour metabolic index using 18F-FDG-PET and 11C-methionine PET

Authors: Miwako Takahashi, Tsutomu Soma, Akitake Mukasa, Keitaro Koyama, Takuya Arai, Toshimitsu Momose

Published in: Annals of Nuclear Medicine | Issue 3/2017

Login to get access

Abstract

Objective

The tumour-to-normal ratio (T/N) is a representative index reflecting brain tumour activity by 18F-fluorodeoxyglucose (FDG) and 11C-methionine (MET) PET. We proposed a new automated method of calculating the normal reference value (N-value) for use as the denomination of T/N. This method uses voxel-based analysis of FDG- and MET-PET images. We compared the results of this method with those of the standard region-of-interest (ROI) method.

Methods

Data sets were obtained from 32 patients with newly diagnosed glioma and 13 patients with recurrent brain tumour. Our methods were as follows: (1) FDG-PET and MET-PET images were co-registered. (2) The areas where the FDG uptake was higher than a set threshold were selected. (3) For the corresponding areas of MET-PET images, mode and mean voxel values were calculated as tentative MET N-values. (4) Applying the same coordinates to FDG-PET, the voxel values were averaged and used as tentative FDG N-values. (5) The threshold of FDG-PET and whether to use the mode or the mean voxel values were computationally optimized using learning data sets. (6) Applying the optimal threshold and either the mode or mean, N-values of FDG and MET were finally determined.

Results

N-values determined by our automated method showed excellent agreement with those determined by a manual ROI method (ICC(2,1) > 0.78). These values were significantly correlated with mean manual N-values (p < 0.001).

Conclusions

Our new method shows sufficiently good agreement with the standard method and can provide a more objective metabolic index.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kaschten B, Stevenaert A, Sadzot B, Deprez M, Degueldre C, Del Fiore G, et al. Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine. J Nucl Med. 1998;39:778–85.PubMed Kaschten B, Stevenaert A, Sadzot B, Deprez M, Degueldre C, Del Fiore G, et al. Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine. J Nucl Med. 1998;39:778–85.PubMed
2.
go back to reference Chung JK, Kim YK, Kim SK, Lee YJ, Paek S, Yeo JS, et al. Usefulness of 11 C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PET. Eur J Nucl Med Mol Imaging. 2002;29:176–82.CrossRefPubMed Chung JK, Kim YK, Kim SK, Lee YJ, Paek S, Yeo JS, et al. Usefulness of 11 C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PET. Eur J Nucl Med Mol Imaging. 2002;29:176–82.CrossRefPubMed
3.
go back to reference Van Laere K, Ceyssens S, Van Calenbergh F, de Groot T, Menten J, Flamen P, et al. Direct comparison of 18F-FDG and 11 C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value. Eur J Nucl Med Mol Imaging. 2005;32:39–51.CrossRefPubMed Van Laere K, Ceyssens S, Van Calenbergh F, de Groot T, Menten J, Flamen P, et al. Direct comparison of 18F-FDG and 11 C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value. Eur J Nucl Med Mol Imaging. 2005;32:39–51.CrossRefPubMed
4.
go back to reference Borbely K, Nyary I, Toth M, Ericson K, Gulyas B. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11 C-methionine in the determination of malignancy of gliomas. J Neurol Sci. 2006;246:85–94.CrossRefPubMed Borbely K, Nyary I, Toth M, Ericson K, Gulyas B. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11 C-methionine in the determination of malignancy of gliomas. J Neurol Sci. 2006;246:85–94.CrossRefPubMed
5.
go back to reference Alavi JB, Alavi A, Chawluk J, Kushner M, Powe J, Hickey W, et al. Positron emission tomography in patients with glioma. A predictor of prognosis. Cancer. 1988;62:1074–8.CrossRefPubMed Alavi JB, Alavi A, Chawluk J, Kushner M, Powe J, Hickey W, et al. Positron emission tomography in patients with glioma. A predictor of prognosis. Cancer. 1988;62:1074–8.CrossRefPubMed
6.
go back to reference Ogawa T, Inugami A, Hatazawa J, Kanno I, Murakami M, Yasui N, et al. Clinical positron emission tomography for brain tumors: comparison of fludeoxyglucose F 18 and L-methyl-11C-methionine. AJNR Am J Neuroradiol. 1996;17:345–53.PubMed Ogawa T, Inugami A, Hatazawa J, Kanno I, Murakami M, Yasui N, et al. Clinical positron emission tomography for brain tumors: comparison of fludeoxyglucose F 18 and L-methyl-11C-methionine. AJNR Am J Neuroradiol. 1996;17:345–53.PubMed
7.
go back to reference Borgwardt L, Hojgaard L, Carstensen H, Laursen H, Nowak M, Thomsen C, et al. Increased fluorine-18 2-fluoro-2-deoxy-D-glucose (FDG) uptake in childhood CNS tumors is correlated with malignancy grade: a study with FDG positron emission tomography/magnetic resonance imaging coregistration and image fusion. J Clin Oncol. 2005;23:3030–7.CrossRefPubMed Borgwardt L, Hojgaard L, Carstensen H, Laursen H, Nowak M, Thomsen C, et al. Increased fluorine-18 2-fluoro-2-deoxy-D-glucose (FDG) uptake in childhood CNS tumors is correlated with malignancy grade: a study with FDG positron emission tomography/magnetic resonance imaging coregistration and image fusion. J Clin Oncol. 2005;23:3030–7.CrossRefPubMed
8.
go back to reference Kajimoto K, Oku N, Kimura Y, Kato H, Tanaka MR, Kanai Y, et al. Crossed cerebellar diaschisis: a positron emission tomography study with L-[methyl-11C]methionine and 2-deoxy-2-[18F]fluoro-D-glucose. Ann Nucl Med. 2007;21:109–13.CrossRefPubMed Kajimoto K, Oku N, Kimura Y, Kato H, Tanaka MR, Kanai Y, et al. Crossed cerebellar diaschisis: a positron emission tomography study with L-[methyl-11C]methionine and 2-deoxy-2-[18F]fluoro-D-glucose. Ann Nucl Med. 2007;21:109–13.CrossRefPubMed
9.
go back to reference Utriainen M, Metsahonkala L, Salmi TT, Utriainen T, Kalimo H, Pihko H, et al. Metabolic characterization of childhood brain tumors: comparison of 18F-fluorodeoxyglucose and 11 C-methionine positron emission tomography. Cancer. 2002;95:1376–86.CrossRefPubMed Utriainen M, Metsahonkala L, Salmi TT, Utriainen T, Kalimo H, Pihko H, et al. Metabolic characterization of childhood brain tumors: comparison of 18F-fluorodeoxyglucose and 11 C-methionine positron emission tomography. Cancer. 2002;95:1376–86.CrossRefPubMed
10.
go back to reference Prieto E, Marti-Climent JM, Dominguez-Prado I, Garrastachu P, Diez-Valle R, Tejada S, et al. Voxel-based analysis of dual-time-point 18F-FDG PET images for brain tumor identification and delineation. J Nucl Med. 2011;52:865–72.CrossRefPubMed Prieto E, Marti-Climent JM, Dominguez-Prado I, Garrastachu P, Diez-Valle R, Tejada S, et al. Voxel-based analysis of dual-time-point 18F-FDG PET images for brain tumor identification and delineation. J Nucl Med. 2011;52:865–72.CrossRefPubMed
11.
go back to reference Okochi Y, Nihashi T, Fujii M, Kato K, Okada Y, Ando Y, et al. Clinical use of (11)C-methionine and (18)F-FDG-PET for germinoma in central nervous system. Ann Nucl Med. 2014;28:94–102.CrossRefPubMed Okochi Y, Nihashi T, Fujii M, Kato K, Okada Y, Ando Y, et al. Clinical use of (11)C-methionine and (18)F-FDG-PET for germinoma in central nervous system. Ann Nucl Med. 2014;28:94–102.CrossRefPubMed
12.
go back to reference Keyes JW, Jr. SUV. standard uptake or silly useless value? J Nucl Med. 1995;36:1836–9.PubMed Keyes JW, Jr. SUV. standard uptake or silly useless value? J Nucl Med. 1995;36:1836–9.PubMed
13.
go back to reference Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull. 1979;86:420–8.CrossRefPubMed Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull. 1979;86:420–8.CrossRefPubMed
14.
go back to reference Shrout PE. Measurement reliability and agreement in psychiatry. Stat Methods Med Res. 1998;7:301–17.CrossRefPubMed Shrout PE. Measurement reliability and agreement in psychiatry. Stat Methods Med Res. 1998;7:301–17.CrossRefPubMed
15.
go back to reference Coope DJ, Cizek J, Eggers C, Vollmar S, Heiss WD, Herholz K. Evaluation of primary brain tumors using 11 C-methionine PET with reference to a normal methionine uptake map. J Nucl Med. 2007;48:1971–80.CrossRefPubMed Coope DJ, Cizek J, Eggers C, Vollmar S, Heiss WD, Herholz K. Evaluation of primary brain tumors using 11 C-methionine PET with reference to a normal methionine uptake map. J Nucl Med. 2007;48:1971–80.CrossRefPubMed
16.
go back to reference Uda T, Tsuyuguchi N, Terakawa Y, Takami T, Ohata K. Evaluation of the accumulation of (11)C-methionine with standardized uptake value in the normal brain. J Nucl Med. 2010;51:219–22.CrossRefPubMed Uda T, Tsuyuguchi N, Terakawa Y, Takami T, Ohata K. Evaluation of the accumulation of (11)C-methionine with standardized uptake value in the normal brain. J Nucl Med. 2010;51:219–22.CrossRefPubMed
17.
go back to reference Galldiks N, Ullrich R, Schroeter M, Fink GR, Jacobs AH, Kracht LW. Volumetry of [(11)C]-methionine PET uptake and MRI contrast enhancement in patients with recurrent glioblastoma multiforme. Eur J Nucl Med Mol Imaging. 2010;37:84–92.CrossRefPubMed Galldiks N, Ullrich R, Schroeter M, Fink GR, Jacobs AH, Kracht LW. Volumetry of [(11)C]-methionine PET uptake and MRI contrast enhancement in patients with recurrent glioblastoma multiforme. Eur J Nucl Med Mol Imaging. 2010;37:84–92.CrossRefPubMed
18.
go back to reference Boss A, Bisdas S, Kolb A, Hofmann M, Ernemann U, Claussen CD, et al. Hybrid PET/MRI of intracranial masses: initial experiences and comparison to PET/CT. J Nucl Med. 2010;51:1198–205.CrossRefPubMed Boss A, Bisdas S, Kolb A, Hofmann M, Ernemann U, Claussen CD, et al. Hybrid PET/MRI of intracranial masses: initial experiences and comparison to PET/CT. J Nucl Med. 2010;51:1198–205.CrossRefPubMed
Metadata
Title
An automated voxel-based method for calculating the reference value for a brain tumour metabolic index using 18F-FDG-PET and 11C-methionine PET
Authors
Miwako Takahashi
Tsutomu Soma
Akitake Mukasa
Keitaro Koyama
Takuya Arai
Toshimitsu Momose
Publication date
01-04-2017
Publisher
Springer Japan
Published in
Annals of Nuclear Medicine / Issue 3/2017
Print ISSN: 0914-7187
Electronic ISSN: 1864-6433
DOI
https://doi.org/10.1007/s12149-017-1153-8

Other articles of this Issue 3/2017

Annals of Nuclear Medicine 3/2017 Go to the issue